$50.73 -0.52 (%) Sanofi Shs Sponsored American Deposit Receipt Repr 1/2 Sh - NYSE

May. 22, 2015 | 04:00 PM

Partner Headlines

  1. Amgen gets cholesterol edge

    IBD | May. 22, 2015 | 18:21PM EST
  2. 3 Top IBD 50 Stocks Hit New All-Time Highs

    IBD | May. 21, 2015 | 16:36PM EST
  3. Move Over Chip Stocks: Here Are 5 Top Biotechs

    IBD | May. 20, 2015 | 09:34AM EST
  4. Move Aside, Chip Stocks, Biotechs Are Leaders Too

    IBD | May. 20, 2015 | 08:02AM EST
  5. Isis Pharma Up As Bayer Licenses Thrombosis Drug

    IBD | May. 4, 2015 | 13:03PM EST
  6. Warren Buffett's Top 10 Dividend Stocks with the Highest Yields

    GuruFocus | Apr. 25, 2015 | 15:24PM EST
  7. Dodge & Cox Stock Fund First Quarter 2015 Commentary

    GuruFocus | Apr. 24, 2015 | 17:34PM EST
  8. Genzyme Initiates Phase 2a Clinical Trial to Evaluate Oral Therapy for Fabry Disease

    Benzinga | Apr. 21, 2015 | 09:03AM EST
  9. Bristol-Myers scores again

    IBD | Apr. 17, 2015 | 19:01PM EST
  10. Bristol's Opdivo Scores Again Against Lung Cancer

    IBD | Apr. 17, 2015 | 16:14PM EST
  11. Bristol's Opdivo Scores Again Against Lung Cancer

    IBD | Apr. 17, 2015 | 10:44AM EST
  12. Making Money With Charles Payne: 04/10/15

    FoxBusiness | Apr. 10, 2015 | 18:00PM EST
  13. Dodge & Cox 2014 Equity Year in Review

    GuruFocus | Feb. 19, 2015 | 18:29PM EST
  14. Why Muscular Dystrophy Is Biotech's Favorite Orphan

    IBD | Feb. 19, 2015 | 16:59PM EST
  15. ENGAGE Randomized Clinical Trial Evaluating Cerdelgafor Treatment-Naïve Patients with Gaucher Disease Type 1 Published in The Journal of the American Medical Association

    Benzinga | Feb. 17, 2015 | 11:36AM EST
  16. Making Money With Charles Payne: 02/13/15

    FoxBusiness | Feb. 13, 2015 | 18:00PM EST
  17. Regeneron Q4 Sales, 2015 Outlook Upbeat On Eylea

    IBD | Feb. 10, 2015 | 10:30AM EST
  18. The Reasons That Make Pfizer A Worthy Hold.

    GuruFocus | Feb. 5, 2015 | 11:19AM EST
  19. Sanofi Posts Higher Q4 Profit

    Benzinga | Feb. 5, 2015 | 05:22AM EST
  20. Fourth Quarter Was Barrow's Slowest Since 2012

    GuruFocus | Feb. 4, 2015 | 17:48PM EST
  21. US Stock Futures Signal Lower Start On Wall Street

    Benzinga | Jan. 26, 2015 | 07:14AM EST
  22. Making Money With Charles Payne: 01/19/15

    FoxBusiness | Jan. 19, 2015 | 18:00PM EST
  23. 10 Biotech Stories You Might've Missed This Week

    Benzinga | Jan. 15, 2015 | 13:18PM EST
  24. Express Scripts Eyes New Price War: Anti-PCSK9 Drugs

    IBD | Jan. 13, 2015 | 19:06PM EST
  25. Cholesterol Drug Costs Eyed

    IBD | Jan. 13, 2015 | 18:51PM EST
  26. Griffin Securities Analyst Thinks New MannKind Management Will Focus On R&D, Not Sanofi Merger

    Benzinga | Jan. 12, 2015 | 15:44PM EST
  27. Why The New MannKind Management Could Focus On R&D, Not A Potential Sanofi Merger

    Benzinga | Jan. 12, 2015 | 15:44PM EST
  28. Guru Stocks at 52-Week Lows: GOOG, VZ, HSBC, SNY, TOT

    GuruFocus | Jan. 12, 2015 | 10:35AM EST
  29. Regeneron rises on drug data

    IBD | Jan. 9, 2015 | 18:42PM EST
  30. Regeneron Jumps On Favorable Cholesterol Drug Report

    IBD | Jan. 9, 2015 | 15:42PM EST
  31. Indexes Slump As Employment Data, Falling Oil Weigh

    IBD | Jan. 9, 2015 | 15:13PM EST
  32. Stocks Stay In Red; Acuity Soars On Strong LED Demand

    IBD | Jan. 9, 2015 | 13:29PM EST
  33. Stocks Reverse Lower On Good News/Bad News Job Data

    IBD | Jan. 9, 2015 | 11:52AM EST
  34. Drugs May Be Blockbusters

    IBD | Jan. 8, 2015 | 18:54PM EST
  35. 5 Potential Blockbuster Drugs Set To Launch In 2015

    IBD | Jan. 8, 2015 | 08:02AM EST
  36. SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against Sanofi ...

    GuruFocus | Jan. 2, 2015 | 15:02PM EST
  37. Guru Stocks at 52-Week Lows: HSBC, SNY, WBK, DCM, BBVA

    GuruFocus | Dec. 23, 2014 | 10:57AM EST
  38. Sanofi Pasteur Announces FDA Approval of Fluzone® Intradermal Quadrivalent (Influenza Vaccine) for Adults

    Benzinga | Dec. 12, 2014 | 08:04AM EST
  39. Zoetis Inc. Spikes Briefly On Remarks From Sanofi CEO

    Benzinga | Dec. 9, 2014 | 15:02PM EST
  40. Two Gauges That Point To Fund Buying In A Stock

    IBD | Dec. 8, 2014 | 18:18PM EST
  41. Merck Acquiring Cubist, Focusing On Hospital Care

    IBD | Dec. 8, 2014 | 11:48AM EST
  42. Mid-Day Market Update: ON Semiconductor Surges On $1 Billion Buyback Plan; POZEN Shares Slip

    Benzinga | Dec. 1, 2014 | 13:43PM EST
  43. Mid-Morning Market Update: Markets Open Lower; Weatherford To Sell Engineered Chemistry, Drilling Fluid Operations to Berkshire's Lubrizol

    Benzinga | Dec. 1, 2014 | 10:23AM EST
  44. Morning Market Losers

    Benzinga | Dec. 1, 2014 | 09:53AM EST
  45. Pharma drugs advance in EU

    IBD | Nov. 21, 2014 | 18:19PM EST
  46. AbbVie, Celgene, Sanofi Drugs Get EU Endorsements

    IBD | Nov. 21, 2014 | 12:28PM EST
  47. Sanofi's Bullish Pipeline Forecast Underwhelms Street

    IBD | Nov. 20, 2014 | 11:44AM EST
  48. Asthma treatment passes trial

    IBD | Nov. 11, 2014 | 18:30PM EST
  49. Guru Stocks at 52-Week Lows: IBM, SNY, SAN, RIO, E

    GuruFocus | Nov. 9, 2014 | 01:58AM EST
  50. Guru Stocks at 52-Week Lows: IBM, BBL, SNY, SAN, RIO

    GuruFocus | Nov. 4, 2014 | 14:23PM EST
Trading Center